According to FutureWise analysis the market for biomarker technologies is expected to reach US$ 122.5 billion by 2031 at a CAGR of 14.5%. Biomarker technologies focus on the identification, measurement, and application of biomarkers—biological indicators that provide quantifiable evidence of physiological or pathological processes within the body. These biomarkers, which can include...